Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CSTA Antikörper (AA 1-98)

Der Kaninchen Monoklonal anti-CSTA Antikörper wird verwendet zum Nachweis von CSTA in Proben von Human. Er wurde validiert für WB und IHC (p).
Produktnummer ABIN7869663
312,40 €
Zzgl. Versandkosten 20,00 € und MwSt
20 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Rekombinanter CSTA Antikörper (AA 1-98) (ABIN7869663)

Target

Alle CSTA Antikörper anzeigen
CSTA (Cystatin A (Stefin A) (CSTA))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 153
  • 46
  • 34
  • 2
Human

Wirt

  • 129
  • 53
Kaninchen

Klonalität

  • 115
  • 67
Monoklonal

Konjugat

  • 72
  • 19
  • 13
  • 6
  • 6
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser CSTA Antikörper ist unkonjugiert

Applikation

  • 125
  • 74
  • 47
  • 27
  • 27
  • 23
  • 21
  • 20
  • 20
  • 14
  • 6
  • 5
  • 5
  • 3
  • 2
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon

CSTA-9087R
  • Bindungsspezifität

    • 46
    • 16
    • 15
    • 12
    • 9
    • 6
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-98

    Verwendungszweck

    Recombinant Cystatin A Antibody / CSTA

    Aufreinigung

    Protein A/G affinity

    Immunogen

    A recombinant fragment of human CSTA protein (within amino acids 1-98) was used as the immunogen for the recombinant Cystatin A antibody.

    Isotyp

    IgG, kappa
  • Applikationshinweise

    1.Optimal dilution of the recombinant Cystatin A antibody should be determined by the researcher.

    2. This recombinant Cystatin A antibody was recombinantly expressed in CHO cells.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.2 mg/mL

    Buffer

    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freeze-thaw cycles

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Aliquot the recombinant Cystatin A antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
  • Target

    CSTA (Cystatin A (Stefin A) (CSTA))

    Andere Bezeichnung

    Cystatin A

    Hintergrund

    Cystatin A antibody targets Cystatin A, a cytoplasmic cysteine protease inhibitor encoded by the CSTA gene and a member of the type I cystatin family. Cystatin A is also widely known as Stefin A and functions as an endogenous inhibitor of papain-like cysteine proteases, including cathepsins B, H, and L. By regulating intracellular protease activity, Cystatin A plays an essential role in protecting epithelial cells from excessive proteolysis and maintaining tissue integrity.

    Cystatin A is predominantly localized in the cytoplasm and is highly expressed in stratified squamous epithelia such as epidermis, oral mucosa, esophagus, and cervix. It is closely associated with epithelial differentiation and keratinization processes, where controlled protease inhibition is required for proper barrier formation. Cystatin A antibody detection is therefore useful for studying epithelial maturation, protease balance, and barrier-related biology.

    Functionally, Cystatin A binds tightly to cysteine proteases and suppresses their enzymatic activity, thereby influencing cellular processes including apoptosis, inflammation, and cell migration. Through modulation of cathepsin activity, Cystatin A contributes to controlled protein turnover and cellular homeostasis. CSTA antibody reagents support research into protease-inhibitor networks that are critical for normal epithelial function and stress responses.

    Altered expression of Cystatin A has been reported in multiple disease contexts, particularly in epithelial-derived cancers. Reduced or heterogeneous CSTA expression has been associated with increased invasiveness and poor differentiation, while strong expression is often retained in well-differentiated squamous cell carcinomas. Changes in Cystatin A levels have also been linked to inflammatory skin disorders and barrier dysfunction, highlighting its relevance in both cancer biology and dermatological research.

    Clone CSTA/9087R is designed to recognize Cystatin A in research applications. Cystatin A antibody reagents are suitable for detecting protein expression and localization in epithelial tissues and tumor samples, supporting investigations into protease regulation, epithelial differentiation, and disease-associated alterations in cysteine protease inhibition.

    UniProt

    P01040

    Pathways

    Response to Water Deprivation
Sie sind hier:
Chat with us!